AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vistin Pharma Director's Dealing 2020

Jun 15, 2020

Director's Dealing

Opens in your device viewer

Mandatory notification of trade in Vistin Pharma ASA

Pactum AS has June 15, 2020, acquired 441,161 shares in Vistin Pharma ASA at NOK 11.80 per share.

CEO of Pactum, Espen W. Marcussen, holds the position as board member in Vistin Pharma ASA.

After the transaction, Pactum AS has a total holding of 3,519,733 shares, corresponding to 7.94%.